Improvement of glycemic control in adults with type 2 diabetes
Who takes it
Adults
Adult dose
For antidiabetic therapy, the dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25mg and metformin hydrochloride extended-release 2000 mg.
To reduce gastrointestinal adverse reactions caused by metformin, take this medicine once daily in the evening with a meal.
Take 1 tablet of this medicine 10/1000 mg extended-release tablet or 25/1000 mg extended-release tablet once daily.
Patients taking this medicine 5/1000 mg extended-release tablet or 12.5/1000 mg extended-release tablet should take 2 tablets together once daily.
To reduce gastrointestinal adverse reactions associated with metformin use, increase the dose of metformin hydrochloride gradually.
To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.
For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended initial total daily dose when taking this medicine is empagliflozin 10 mg and the patient's existing dose of metformin. If empagliflozin 10 mg is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg.
Patients switching from combination therapy with empagliflozin and metformin to this medicine should receive their existing doses of empagliflozin and metformin.
When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate.
When this medicine is administered concomitantly with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of hypoglycemia.
No dose adjustment of this medicine is required in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 m2].
In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60mL/min/1.73m2] who tolerate treatment well and do not have other conditions that may increase the risk of lactic acidosis, this medicine may be used with adjustment of the metformin hydrochloride dose as follows.
- Since the starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000mg.
If creatinine clearance (CrCl) decreases to less than 45 ml/min or estimated glomerular filtration rate (eGFR) decreases to less than 45 ml/min/1.73m2, this medicine must be discontinued immediately.
In patients 75 years of age and older, renal function and the risk of volume depletion should be considered.
Improvement of glycemic control in adults with type 2 diabetes
Difficulty controlling blood sugar
type 2 diabetes
cardiovascular disease
View approved original textHide original text
This medication is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. In particular, the combination of empagliflozin and metformin effectively manages blood sugar levels. For patients with cardiovascular disease whose blood sugar is not adequately controlled, special attention is required, and it is important to refer to relevant clinical trial information. This medication helps to provide safe and effective blood sugar management, contributing positively to diabetes treatment.
How to take
Adult dose
For antidiabetic therapy, the dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25mg and metformin hydrochloride extended-release 2000 mg.
To reduce gastrointestinal adverse reactions caused by metformin, take this medicine once daily in the evening with a meal.
Take 1 tablet of this medicine 10/1000 mg extended-release tablet or 25/1000 mg extended-release tablet once daily.
Patients taking this medicine 5/1000 mg extended-release tablet or 12.5/1000 mg extended-release tablet should take 2 tablets together once daily.
To reduce gastrointestinal adverse reactions associated with metformin use, increase the dose of metformin hydrochloride gradually.
To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.
For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended initial total daily dose when taking this medicine is empagliflozin 10 mg and the patient's existing dose of metformin. If empagliflozin 10 mg is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg.
Patients switching from combination therapy with empagliflozin and metformin to this medicine should receive their existing doses of empagliflozin and metformin.
When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate.
When this medicine is administered concomitantly with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of hypoglycemia.
No dose adjustment of this medicine is required in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 m2].
In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60mL/min/1.73m2] who tolerate treatment well and do not have other conditions that may increase the risk of lactic acidosis, this medicine may be used with adjustment of the metformin hydrochloride dose as follows.
- Since the starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000mg.
If creatinine clearance (CrCl) decreases to less than 45 ml/min or estimated glomerular filtration rate (eGFR) decreases to less than 45 ml/min/1.73m2, this medicine must be discontinued immediately.
In patients 75 years of age and older, renal function and the risk of volume depletion should be considered.
Precautions
This medication helps control blood sugar. However, it should not be used in cases of poor kidney function or acute illnesses.
This medication can rarely cause a condition known as lactic acidosis, which can be life-threatening, so caution is necessary. If sudden muscle pain, weakness, difficulty breathing, or abdominal pain occurs, immediate medical attention is required.
Furthermore, when used with other diabetes medications, caution is necessary to avoid hypoglycemia caused by excessively low blood sugar.
Urinary tract infections or genital infections may occur, so prompt treatment is necessary if infection symptoms arise.
This medication can affect the body's fluid levels, necessitating special caution for patients with dehydration symptoms or the elderly.
Patients with impaired liver or kidney function must consult a doctor before taking this medication and should have regular kidney function tests.
Pregnant or breastfeeding women are advised not to take this medication, and those planning a pregnancy should consult a doctor.
Additionally, this medication should be swallowed whole and not crushed or chewed, although the tablet coating may be expelled in stool, which is normal.
It is advisable to avoid alcohol consumption while taking this medication, and patients should notify their healthcare provider of any sudden surgical procedures or radiological contrast examinations.
Lastly, during the course of taking this medication, regular monitoring of blood sugar and kidney function is necessary, and immediate consultation with a healthcare provider is required if any abnormal symptoms occur.
Side effects
Hypoglycemia
urinary tract infection
genital infection
increased urination
decreased and deficiency of vitamin B12
ketoacidosis
lactic acidosis
nausea
vomiting
diarrhea
Show 200 moreCollapse
abdominal pain
loss of appetite
constipation
abnormal liver function tests
hepatitis
taste disturbance
itching
rash
urticaria
erythema
angioedema
dysuria
interstitial nephritis
thirst
increased serum lipids
increased serum creatinine
decreased glomerular filtration rate
perineal necrosis
vulvovaginitis
balanitis
decreased body fluid volume
fluid loss
increased serum creatinine
decreased glomerular filtration rate
chronic gastritis
cerebral infarction
soft tissue infection
pneumonia
ankle fracture
epicondylitis
facial bone fracture
musculoskeletal pain
myocardial infarction
ketoacidosis
urosepsis
pyelonephritis
rash
urticaria
angioedema
perineal necrosis
diarrhea
nausea
gastric ulcer
colitis
vomiting
ischemic colitis
colonic bleeding
appendiceal abscess
appendicitis
meningitis
chronic otitis media
peritonsillar abscess
pulmonary tuberculosis
acute pyelonephritis
sepsis
subcutaneous abscess
tubo-ovarian abscess
vestibular neuritis
acute pyelonephritis
headache
cerebral infarction
intracranial aneurysm
fever
vascular stent stenosis
vascular stent thrombosis
increased alanine aminotransferase
increased aspartate aminotransferase
ureterolithiasis
acute kidney injury
ureterolithiasis
cervical inflammation
hyperglycemia
hyponatremia
dizziness
chest discomfort
chest pain
weakness
vulvar itching
genital itching
dyslipidemia
low back pain
diabetic retinopathy
dry eyes
cough
shortness of breath
unstable angina
hypertension
insomnia
anemia
lymphadenopathy
hypothyroidism
thyroid nodule
constipation
nasopharyngitis
herpes zoster
dizziness
headache
chest discomfort
chest pain
weakness
weight loss
vulvar itching
genital itching
hypoglycemia
decreased appetite
somnolence
diabetes mellitus
hyperlipidemia
hyponatremia
dermoid cyst
seborrheic dermatitis
atopic dermatitis
diabetic foot
nummular eczema
heat rash
sebaceous gland hyperplasia
lumbar spinal stenosis
myalgia
limb pain
musculoskeletal chest pain
arthralgia
cervical stenosis
fibromyalgia
flank pain
fracture pain
muscle weakness
musculoskeletal pain
osteoarthritis
osteoporosis
rotator cuff syndrome
astigmatism
cataract
allergic conjunctivitis
blurred vision
corneal erosion
glaucoma
macular fibrosis
ocular discomfort
conjunctival hyperemia
pathological myopia
retinal detachment
retinal deposits
retinal vein occlusion
lattice retinal detachment
eyelid swelling
visual impairment
vitreous floaters
vitreous hemorrhage
epistaxis
asthma
exertional dyspnea
wet cough
allergic rhinitis
residual sputum
cough
epistaxis
allergic rhinitis
limb injuries
skin lacerations
contusions
rib fractures
concussion
corneal abrasion
falls
hand fractures
iliolumbar ligament syndrome
open globe injury
pelvic fracture
road traffic accidents
splenic injury
sternum fracture
skin lacerations
rib fractures
iliolumbar ligament syndrome
angina
palpitations
Prinzmetal angina
coronary artery disease
tachycardia
atherosclerosis
deep vein thrombosis
diabetic vascular complications
peripheral arterial occlusive disease
anxiety
depression
sleep disorders
anxiety
acute cholecystitis
autoimmune hepatitis
cholelithiasis
hepatitis
otalgia
positional vertigo
vertigo
otalgia
positional vertigo
anemia
lymphadenopathy
hypothyroidism
thyroid nodule
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, at room temperature between 1 to 30 degrees Celsius.
Proper storage will help maintain the medication's effectiveness and prevent deterioration.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.